Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma
- PMID: 33392922
- DOI: 10.1007/s11010-020-03999-x
Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma
Abstract
Latest strategies for cancer treatment primarily focus on the use of chemosensitizers to enhance therapeutic outcome. N-3 PUFAs have emerged as the strongest candidate for the prevention of colorectal cancer (CRC). Our previous studies have demonstrated that fish oil (FO) rich in n-3 PUFAs not only increased therapeutic potential of 5-Fluorouracil(5-FU) in colon cancer but also ameliorated its toxicity. Henceforth, the present study is designed to elucidate mechanistic insights of FO as a chemosensitizer to circumvent drug resistance in experimental colon carcinoma. The colon cancer was induced by 1,2-dimethylhydrazine(DMH)/dextran sulfate sodium(DSS) in male Balb/c mice and these animals were treated with 5-FU(12.5 mg/kg b.w.), FO(0.2 ml), or 5-FU + FO(12.5 mg/kg b.w + 0.2 ml) orally for 14 days. The molecular mechanism of overcoming 5-FU resistance using FO in colon cancer was delineated by estimating expression of cancer stem cell markers using flowcytometric method and drug transporters by immunohistochemistry and immunoblotting. Additionally, distribution profile of 5-FU and its cytotoxic metabolite, 5-FdUMP at target(colon), and non-target sites (serum, kidney, liver, spleen) was assessed using high-performance liquid chromatography(HPLC) method. The observations revealed that expression of CSCs markers was remarkably reduced after using fish oil along with 5-FU in carcinogen-treated animals. Interestingly, the use of FO alongwith 5-FU also significantly declined the expression of drug transporters (ABCB1,ABCC5) and consequently resulted in an increased cellular uptake of 5-FU and its metabolite, 5-FdUMP at target site (colon). It could be possibly associated with change in permeability of cell membrane owing to the alteration in membrane fluidity. The present study revealed the mechanistic insights of FO as a MDR revertant which successfully restored 5-FU-mediated chemoresistance in experimental colon carcinoma.
Keywords: 5-Fluoro-2′-deoxyuridine 5′ monophosphate (5-FdUMP); 5-Fluorouracil (5-FU); ATP-binding cassette (ABC) transporters; Colorectal cancer (CRC); Fish oil (FO); Multi drug resistance (MDR).
Similar articles
-
Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis.Cancer Chemother Pharmacol. 2014 Aug;74(2):309-22. doi: 10.1007/s00280-014-2497-6. Epub 2014 Jun 11. Cancer Chemother Pharmacol. 2014. PMID: 24916547
-
IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells.Cancer Lett. 2020 Apr 28;476:67-74. doi: 10.1016/j.canlet.2020.02.007. Epub 2020 Feb 12. Cancer Lett. 2020. PMID: 32061752
-
Apoptosis mediated chemosensitization of tumor cells to 5-fluorouracil on supplementation of fish oil in experimental colon carcinoma.Tumour Biol. 2017 Mar;39(3):1010428317695019. doi: 10.1177/1010428317695019. Tumour Biol. 2017. PMID: 28349837
-
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.Cancer Drug Resist. 2023 Apr 29;6(2):257-272. doi: 10.20517/cdr.2022.136. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37457133 Free PMC article. Review.
-
Multiple strategies with the synergistic approach for addressing colorectal cancer.Biomed Pharmacother. 2021 Aug;140:111704. doi: 10.1016/j.biopha.2021.111704. Epub 2021 May 31. Biomed Pharmacother. 2021. PMID: 34082400 Review.
Cited by
-
To explore the prognostic efficacy and mechanism of ABCC5 clinical scoring model in hepatocellular carcinoma.Front Oncol. 2025 Aug 11;15:1519533. doi: 10.3389/fonc.2025.1519533. eCollection 2025. Front Oncol. 2025. PMID: 40860808 Free PMC article.
-
The Salmon Oil OmeGo Reduces Viability of Colorectal Cancer Cells and Potentiates the Anti-Cancer Effect of 5-FU.Mar Drugs. 2023 Dec 12;21(12):636. doi: 10.3390/md21120636. Mar Drugs. 2023. PMID: 38132957 Free PMC article.
-
Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target.Front Cell Dev Biol. 2024 Nov 5;12:1446418. doi: 10.3389/fcell.2024.1446418. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39563862 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA: A Cancer J Clin 69:7–34
-
- Battista T, Fiorillo A, Chiarini V, Genovese I, Ilari A, Colotti G (2020) Roles of Sorcin in drug resistance in Cancer: one protein, many mechanisms, for a novel potential anticancer drug target. Cancers (Basel) 12(4):887. https://doi.org/10.3390/cancers12040887 - DOI
-
- Kang KA, Piao MJ, Kim KC, Kang HK, Chang WY, Park IC, Keum YS, Surh YJ, Hyun JW (2014) Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation. Cell Death Dis 5:e1183 - DOI
-
- Noordhuis P, Holwerda U, Van der Wilt CL, Van Groeningen CJ, Smid K, Meijer S, Pinedo HM, Peters GJ (2004) 5-fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol 15:1025–1032 - DOI
-
- Lee JY, Sim TB, Lee JE, Na HK (2017) Chemopreventive and chemotherapeutic effects of fish oil derived Omega-3 polyunsaturated fatty acids on Colon carcinogenesis. Clin Nutr Res 6(3):147–160. https://doi.org/10.7762/cnr.2017.6.3.147 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources